SpyGlass™ Discover Percutaneous

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

December 14, 2022

Study Completion Date

January 14, 2023

Conditions
Pancreatic DiseasesBile Duct ObstructionBile Duct Diseases
Interventions
DEVICE

SpyGlass™ Discover Digital System

Observational, prospective, registry study for the clinical utility of the SpyGlass Discover digital catheter during a PTCS procedure.

Trial Locations (7)

1070

Erasme University Hospital, Brussels

40217

Evangelisches Krakenhaus Düsseldorf, Düsseldorf

98101

Virginia Mason Medical Center, Seattle

999077

Prince of Wales Hospital, Shatin

M5G2N2

Toronto General Hospital, University Health Network, Toronto

500-082

Asian Institute of Gastroenterology, Hyderabad

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT04580940 - SpyGlass™ Discover Percutaneous | Biotech Hunter | Biotech Hunter